SCHEMBL4528062

SCHEMBL4528062

NC(=S)Nc1cccc(S(=O)(=O)CCO)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.49
CYP1A2 P05177 1/20 0.47
ALDH1A1 P00352 5/20 0.46
MAPK10 P53779 1/20 0.46
CA2 P00918 9/20 0.44
CA1 P00915 8/20 0.44
PKM P14618 2/20 0.44
MEN1 O00255 2/20 0.44
CA9 Q16790 6/20 0.44
CA12 O43570 4/20 0.44
TP53 P04637 1/20 0.43
TYR P14679 1/20 0.43
TSHR P16473 1/20 0.43
TAS2R38 P59533 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6814618 0.82 ALDH1A1 (0.52) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL6814608 0.82 ALDH1A1 (0.49) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL8516324 0.81 CA2 (0.47) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL4522845 0.80 CA1 (0.64) ALDH1A1CA2CA1PKMCA9
SCHEMBL27785864 0.80 ALDH1A1 (0.45) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL7031844 0.78 ALDH1A1 (0.46) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL4524583 0.78 CYP1A2 (0.57) KMT2ACYP1A2ALDH1A1CA2CA1
SCHEMBL7933997 0.78 CA1 (0.50) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL7084160 0.77 ALDH1A1 (0.54) KMT2AALDH1A1MAPK10CA2CA1
SCHEMBL11419583 0.76 ALDH1A1 (0.59) KMT2AALDH1A1MAPK10CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150561-B2 Thiazole derivatives and use thereof MERCK SERONO S.A. (CH) 2015-10-06 US disclosed
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF MERCK SERONO S.A. (CH) 2014-08-14 US disclosed
US-8802861-B2 Thiazole derivatives and use thereof MERCK SERONO SA (CH) 2014-08-12 US disclosed
US-20090029998-A1 Thiazole Derivatives and Use Thereof APPLIED RESEARCH SYSTEM ARS HOLDING N.V. (NL) 2009-01-29 US disclosed
EP-1709019-B1 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS (AN) 2007-08-08 EP disclosed
EP-1709019-A2 THIAZOLE DERIVATIVES AND USE THEREOF Applied Research Systems ARS Holding N.V. (AN) 2006-10-11 EP disclosed
WO-2005068444-A2 THIAZOLE DERIVATIVES AND USE THEREOF APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-07-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228365-A1 THIAZOLE DERIVATIVES AND USE THEREOF PF4, TEC, PDGFRB KMT2A 4760/4885CYP1A2 2522/4885ALDH1A1 234/4885
US-20090029998-A1 Thiazole Derivatives and Use Thereof PDGFRB, PDGFRA, TEC KMT2A 4737/4885CYP1A2 2078/4885ALDH1A1 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.